Product Main

Quick Details

Purity: 99%
Model Number: 319460-85-0
Brand Name: NJBN STEROID
Grade Standard: Medicine Grade
Type: Cancer Therapy
Place of Origin: China (Mainland)
EINECS No.: 319460-85-0
MF: C22H18N4OS
Other Names: Benzamide
CAS No.: 319460-85-0
Sample: Free
Market: Worldwide

Specifications

Axitinib Raw Materials For Cancer Therapy 319460-85-0 99%

_____________________________________________________________________________________________________________

Axitinib

Synonyms: AXITINIB; Benzamide, N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-; N-METHYL-2-{[3-((E)-2-PYRIDIN-2-YLVINYL)-1H-INDAZOL-6-YL]SULFANYL}BENZAMIDE; N-Methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide; AVERMECTINB; Axitinib for research; AG013736; N-Methyl-2-[[3-[(1E)- 2-(2-pyridinyl)ethenyl] -1H-indazol-6-yl]thio]benzamide
CAS: 319460-85-0
MF: C22H18N4OS
MW: 386.47
Purity: 99%
Appearance: White to off-White Powder
Categories:
All Inhibitors; Inhibitors; Intermediates & Fine Chemicals; Pharmaceuticals; Protein Kinase Inhibitors and Activators; Pfizer compounds; API; AG 013736


_____________________________________________________________________________________________________________

COA

Items of analysis

Specification

Results

Description

off-white powder

Conforms

Loss on drying

NMT 1.0%

0.7%

Water content

NMT 0.5%

0.13%

Single impurity

NMT0.1%

0.07%

Total impurity

NMT 0.5%

0.29%

Purity(HPLC)

NLT 99.0%

99.71%

Conclusion

Qualified



_____________________________________________________________________________________________________________


Description of Axitinib

Axitinib is a small molecule tyrosine kinase inhibitor developed . It has been shown to significantly inhibit growth of breast cancer in animal (xenograft) models and has shown partial responses in clinical trials with renal cell carcinoma (RCC) and several other tumour types. It has been shown to significantly Inhibit growth of breast cancer in xenograft models and has been successful in trials with renal cell carcinoma (RCC) and several other tumor types.

_____________________________________________________________________________________________________________


Hot selling pharmaceutical raw materials

Clarithromycin CAS: 81103-11-9
PF-2341066/Crizotinib CAS: 877399-52-5
Rapamycin CAS: 53123-88-9
Trilostane CAS: 13647-35-3
Tacrolimus CAS: 104987-11-3
Ketoconazole CAS: 65277-42-1
Levamisole hydrochloride CAS: 16595-80-5
Daunorubicin hydrochloride CAS: 23541-50-6
Folic acid CAS: 59-30-3
Itraconazole CAS: 84625-61-6
Everolimus CAS: 159351-69-6
Zoledronic acid CAS: 118072-93-8
Aminoglutethimide (Cytadren) CAS: 125-84-8
Rasagiline mesylate CAS: 161735-79-1
Clopidogrel hydrogen sulfate CAS: 135046-48-9
Doxepin hydrochloride CAS: 1229-29-4
Naphazoline hydrochloride CAS: 550-99-2
TELMISARTAN CAS: 144701-48-4
Pramipexole CAS: 104632-26-0
Furazabol CAS: 1239-29-8
Triamcinolone acetonide CAS: 76-25-5
Etilefrine hydrochloride CAS: 943-17-9
Promethazine hydrochloride CAS: 58-33-3
O-PHOSPHORYLETHANOLAMINE CAS: 1071-23-4
Cilastatin CAS : 82009-34-5
Lovastatin CAS: 75330-75-5
Erythromycin CAS: 114-07-8
Pregabalin / Lyrica CAS: 148553-50-8
DEXTROMETHORPHAN HYDROBROMIDE CAS: 125-69-9
Macitentan CAS: 441798-33-0
Etoricoxib CAS: 202409-33-4
PARECOXIB SODIUM CAS: 198470-85-8
Tirofiban hydrochloride monohydrate CAS: 150915-40-5
Apixaban CAS: 503612-47-3
Palbociclib CAS: 571190-30-2
Anacetrapib CAS: 875446-37-0
Dexamethasone CAS: 50-02-2
Dutasteride CAS: 164656-23-9
Finasteride CAS: 98319-26-7